NFKB1 and cancer: The overexpression of cIAPs observed in tumors reinforces the pro-survival NF-κB pathway, making the cIAP-RIP1-TAK1-NF-κB axis a target for therapeutic intervention aimed at re-sensitizing cancer cells to death.